10,33 Similarly, the REWIND trial, in patients with T2D and established CVD or cardiovascular risk factors, reported that dulaglutide significantly reduced the incidence of MACE (primary outcome)
People often report eating a lot less when taking semaglutide medications
In other words, a faulty instruction manual (MTHFR gene) seems to be the key behind certain health issues
To evaluate whether biased agonism translates into improved efficacy for weight loss and glycemic control in clinical settings, we developed and characterized CT-388, a unimolecular peptide-based dual GLP-1R/GIPR agonist that is cAMP signal-biased at both receptors
Lund ML, Egerod KL, Engelstoft MS, et al
doi: 10.1136/jnnp-2024-335593 [DOI] [PMC free article] [PubMed] [Google Scholar] 124